Home LiteratureArticle Details
PMID: 36923118 Published · epublish English Journal Article

Exploring the common pathogenesis of Alzheimer's disease and type 2 diabetes mellitus via microarray data analysis.

Frontiers in aging neuroscience ·Vol. 15 ·2023-00-00 ·页码 1071391

Ye XW, Liu MN, Wang X, Cheng SQ, Li CS, Bai YY, Yang LL, Wang XX, Wen J, Xu WJ, Zhang SY, Xu XF, Li XR

Abstract

Alzheimer's Disease (AD) and Type 2 Diabetes Mellitus (DM) have an increased incidence in modern society. Although more and more evidence has supported that DM is prone to AD, the interrelational mechanisms remain fully elucidated. The primary purpose of this study is to explore the shared pathophysiological mechanisms of AD and DM. Download the expression matrix of AD and DM from the Gene Expression Omnibus (GEO) database with sequence numbers GSE97760 and GSE95849, respectively. The common differentially expressed genes (DEGs) were identified by limma package analysis. Then we analyzed the six kinds of module analysis: gene functional annotation, protein-protein interaction (PPI) network, potential drug screening, immune cell infiltration, hub genes identification and validation, and prediction of transcription factors (TFs). The subsequent analyses included 339 common DEGs, and the importance of immunity, hormone, cytokines, neurotransmitters, and insulin in these diseases was underscored by functional analysis. In addition, serotonergic synapse, ovarian steroidogenesis, estrogen signaling pathway, and regulation of lipolysis are closely related to both. DEGs were input into the CMap database to screen small molecule compounds with the potential to reverse AD and DM pathological functions. L-690488, exemestane, and BMS-345541 ranked top three among the screened small molecule compounds. Finally, 10 essential hub genes were identified using cytoHubba, including PTGS2, RAB10, LRRK2, SOS1, EEA1, NF1, RAB14, ADCY5, RAPGEF3, and PRKACG. For the characteristic Aβ and Tau pathology of AD, RAPGEF3 was associated significantly positively with AD and NF1 significantly negatively with AD. In addition, we also found ADCY5 and NF1 significant correlations with DM phenotypes. Other datasets verified that NF1, RAB14, ADCY5, and RAPGEF3 could be used as key markers of DM complicated with AD. Meanwhile, the immune cell infiltration score reflects the different cellular immune microenvironments of the two diseases. The common pathogenesis of AD and DM was revealed in our research. These common pathways and hub genes directions for further exploration of the pathogenesis or treatment of these two diseases.

Keywords
Alzheimer’s disease bioinformatics analysis network pharmacology pathophysiological mechanisms type 2 diabetes mellitus
作者与单位
共 13 位作者,点击展开单位 / ORCID
Ye Xian-Wen
Centre of TCM Processing Research, Beijing University of Chinese Medicine, Beijing, China. | Beijing Key Laboratory for Quality Evaluation of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China. | School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Liu Meng-Nan
Centre of TCM Processing Research, Beijing University of Chinese Medicine, Beijing, China. | School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Wang Xuan
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Cheng Shui-Qing
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Li Chun-Shuai
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Bai Yu-Ying
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Yang Lin-Lin
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Wang Xu-Xing
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Wen Jia
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Xu Wen-Juan
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Zhang Shu-Yan
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Xu Xin-Fang
Centre of TCM Processing Research, Beijing University of Chinese Medicine, Beijing, China. | Beijing Key Laboratory for Quality Evaluation of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China. | School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Li Xiang-Ri
Centre of TCM Processing Research, Beijing University of Chinese Medicine, Beijing, China. | Beijing Key Laboratory for Quality Evaluation of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China. | School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Article Info
Journal
Frontiers in aging neuroscience
Abbr.
Front Aging Neurosci
ISSN
1663-4365
Published
2023-00-00
电子出版
2023-00-27
页码
1071391
Language
English
Country/Region
Switzerland
NLM ID
101525824
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com